By Topic

New Implantable Hearing Device Based on a Micro-Actuator that is Directly Coupled to the Inner Ear Fluid

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$31 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

3 Author(s)
Bernhard, H. ; Helbling Technik Bern AG, Liebefeld ; Stieger, C. ; Perriard, Y.

A new hearing therapy called direct acoustical cochlear stimulation (DACS) was developed and validated in a first clinical trial with four patients. The key component of this therapy based on an implantable hearing device is a micro-actuator that is implanted in the mastoid right behind the external auditory canal of a patient. It generates vibrations that are directly coupled to the inner ear fluids and bypass therefore the outer and the middle ear. This allows treating severe to profound mixed hearing loss. The actuator transfer function has to be similar to the transfer function of a normal human middle ear to guarantee high system efficiency. A balanced armature actuator was the ideal transducer type in order to meet this requirement considering the given restrictions in size and shape

Published in:

Engineering in Medicine and Biology Society, 2006. EMBS '06. 28th Annual International Conference of the IEEE

Date of Conference:

Aug. 30 2006-Sept. 3 2006